Literature DB >> 5059642

Metabolism of the third component of complement (C3) in patients with rheumatoid arthritis.

A Weinstein, K Peters, D Brown, R Bluestone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5059642     DOI： 10.1002/art.1780150108

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  20 in total

1.  Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis.

Authors:  D D McGavin; J Williamson; J V Forrester; W S Foulds; W W Buchanan; W C Dick; P Lee; R N MacSween; K Whaley
Journal:  Br J Ophthalmol       Date:  1976-03       Impact factor: 4.638

2.  Cryoimmunoglobulinemia in rheumatoid arthritis. Significance in serum of patients with rheumatoid vasculitis.

Authors:  M Weisman; N Zvaifler
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

3.  Immunoglobulins and complement components in synovial fluid of patients with acute rheumatic fever.

Authors:  M Svartman; E V Potter; T Poon-King; D P Earle
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

4.  Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease.

Authors:  R H Zubler; U Nydegger; L H Perrin; K Fehr; J McCormick; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

5.  Serum immunoglobulin and beta 1C-beta 1A globulin concentrations in juvenile rheumatoid arthritis.

Authors:  K M Goel; R W Logan; W P Barnard; R A Shanks
Journal:  Ann Rheum Dis       Date:  1974-01       Impact factor: 19.103

6.  Complement (C3) metabolism in rheumatoid arthritis in relation to the disease course.

Authors:  A J Swaak; H Han; A van Rooyen; M Pillay; C E Hack
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

7.  Simultaneous turnover of normal and dysfunctional C1 inhibitor as a probe of in vivo activation of C1 and contact activatable proteases.

Authors:  P Woo; P J Lachmann; R A Harrison; N Amos; C Cooper; F S Rosen
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

8.  C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.

Authors:  K Whaley; P H Schur; S Ruddy
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

9.  The association of cryoglobulinaemia with nodules, vasculitis and fibrosing alveolitis in rheumatoid arthritis and their relationship to serum C1q binding activity and rheumatoid factor.

Authors:  C C Erhardt; P Mumford; R N Maini
Journal:  Clin Exp Immunol       Date:  1979-12       Impact factor: 4.330

10.  Spontaneous nasal septal perforation in patients with rheumatoid arthritis.

Authors:  J L Mathews; J R Ward; C O Samuelson; W P Knibbe
Journal:  Clin Rheumatol       Date:  1983-03       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.